Biosimilar Drug Development Europe 2016


Navigate development and launch strategies for biosimilars






The industry is rapidly changing, which provides a unique set of challenges for those developing and manufacturing biosimilars. Gain true insight on winning development, manufacturing, clinical and commercialization strategies for biosimilars in the global market.

Navigate the challenges in the clinic, and the manufacture and development of biosimilar medicines as well as explore the commercial hot topics in the industry.
This is your best chance to find out where the true biosimilar industry growth opportunities lie and what role they can play in your portfolio.

Download Biosimilar Drug Development brochure for full details about:

  • Event speakers
  • Full event programme
  • Event format
  • Why you should be there
  • Networking opportunities 
  • Our community
  • Prices and discounts
  • And much more!

This brochure will give you a full overview of what to expect at the event.


Your Sponsorship Opportunity



Biosimilar Drug Development Europe 2016 prospectus

The 4th annual Biosimilar Drug Development World Europe 2015 event is a senior level two-day interactive conference that provides delegates with the strategic and scientific knowledge and connections to help navigate the challenges in the development, production and launch of these complex medicines.

It is a place where innovation is showcased, learning is done and new business contacts are made

Increase your brand awareness and demonstrate thought leadership in front of over 200 senior representatives from biosimilar and generic pharma companies.It's that simple.
Skip the hard work of attending tons of small industry meetups and networking events. Take back a handful of leads after just two days. 


Download Sponsorship Brochure



Biosimilar Drug Development attendees include





Bristol Myers Squibb

Boehringer Ingelheim

Johnson and Johnson







Full Attendee list



"Very nice congress, good speakers, interesting colleagues, well organised"
Strategic Alliance Manager Clinical Sciences, Bayer AG




 Keynote Speakers

Caroline Boulliat

Caroline Boulliat

Immunology Franchise Head Biosimilar EMA,  Hospira

Analysing current market trends to understand
how to drive biosimilar commercial success



Malcolm I Mitchell

Malcolm I Mitchell

Senior Medical Fellow, Clincal Pharmacology,
Eli Lilly & Company

A clinical pharmacologist’s view of biosimilars

Klaus Martin

Klaus Martin

Senior Director, Business and Product Development,
Polpharma Biologics

Development and process considerations
for biosimilars


Sandeed Athalye

Sandeep Athalye
Vice President and Head, CDMA, Biosimilars,  Boehringer Ingelheim

The future of the biosimilar industry - mapping
the evolution and development of the biosimilar sector


Download Sponsorship Brochure





The speakers and topics were very useful for my business and development
Senior Manager, Cubist Pharmaceuticals



Formats to Excite


We know listening to presentation after presentation at conferences can be quite boring.  So, we've introduced some new formats to inspire you during your 2 days with us.  With interactive roundtable sessions providing a new way of discussing topics with your peers, to lively panel discussions and Q&A's, all the way to a post conference party - we have everything to keep you engaged and maximise your learning at the event.


Biosimilar Drug Development 2016 networking lunch

Networking lunches

Biosimilar Drug Development dinner party

Post conference party

Biosimilar Drug Development round tables

Roundtable sessions

Biosimilar Drug Development speed networking

Speed Networking